Grifols awarded Gold Medal by EcoVadis for Sustainability Excellence

Barcelona, Spain, Nov. 5, 2024 - Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announced that it has been awarded a Gold Medal by EcoVadis, a leading global corporate sustainability rating platform, for the second consecutive year.

Achieving a score of 77 out of 100 – an improvement of three points over last year – Grifols  now ranks among the top 5% of the more than 100,000 companies evaluated by EcoVadis across 200 sectors and 175 countries.

EcoVadis medals take into account a company’s performance over the last year against that of all rated companies in EcoVadis’ database. The percentile rank is calculated across all industries and not by each sector individually. Grifols is positioned in the 97th percentile, a distinction underscoring its continuous efforts in environmental stewardship, social responsibility and ethical governance.

This year, Grifols’ commitment to sustainable procurement and responsible practices received particular recognition, alongside its strong performance in environmental practices, labor practices and human rights, in addition to ethical leadership.

"This recognition reflects Grifols’ steadfast commitment to building a more sustainable and responsible value chain,” said Daniel Segarra, VP of Investor Relations and Sustainability at Grifols. “As a healthcare company, we strive not only to enhance patient health but also to reduce our environmental impact while upholding the highest standards of ethics and social responsibility."

EcoVadis evaluates companies across four key pillars: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement, benchmarking against international standards such as the UN Global Compact and the Global Reporting Initiative.

For more information on Grifols’ ESG initiatives and progress, please visit Sustainability | Grifols and read more in our Integrated and Sustainability Annual Report.